美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫藥外包概念

1,462.72

-16.3195-1.10%

漲家數：- -

跌家數：2

平家數：1

市盈率：- -

高：1,486.96

開：1,463.31

低：1,435.38

收：1,479.03

成交量：31.82萬

成交額：5,353.62萬

市值：367.29億

流通市值：352.68億

資料載入中...

總覽新聞資訊

FDA 連發多份 CRL，開年大批新藥上市申請已遭拒

查爾斯河公司出售表現不佳資產，上調年度利潤預期

查爾斯河國際實驗室：資產剝離預計將使2026年營收縮減逾2億美元

艾昆緯簽署協議收購查爾斯河實驗室藥物發現資產，拓展端到端藥物研發能力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/BK4530/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":1462.7153,"timestamp":1773327210304,"preClose":1479.0348,"halted":0,"volume":318234,"delay":0,"changeRate":-0.011034,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-16.319458,"latestTime":"03-12 10:53:34 EDT","open":1463.3119,"high":1486.9631,"low":1435.3815,"amount":53536218.01854,"amplitude":0.034875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773345600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.820238,"peRate":30.380689,"turnoverRate":0.001525,"increases":0,"decrements":2,"flats":0,"marketCap":36728644608,"floatMarketCap":35267950080},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1486.9631,"amplitude":0.034875,"preClose":1479.0348,"low":1435.3815,"pbRate":"3.820238","latestPrice":1462.7153,"volume":318242,"delay":0,"open":1463.3119,"prevYearClose":1899.2574,"prevWeekClose":1509.4452,"prevMonthClose":1546.1846,"prevQuarterClose":1899.2574,"fiveDayClose":1549.5038,"twentyDayClose":1509.6383,"sixtyDayClose":1864.7571,"secType":"PLATE","market":"US","turnoverRate":0.001525,"peRate":30.380689,"marketCap":36728644608,"floatMarketCap":35267950080,"timestamp":1773327216551,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":0,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618157119","title":"FDA 連發多份 CRL，開年大批新藥上市申請已遭拒","url":"https://stock-news.laohu8.com/highlight/detail?id=2618157119","media":"制药网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618157119?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 14:39","pubTimestamp":1773211194,"startTime":"0","endTime":"0","summary":"2026年以来，全球医药企业就遭遇了FDA的CRL风暴。2月14日消息，Disc Medicine备受瞩目的候选药物Bitopertin用于治疗罕见血液病红细胞生成性卟啉症的上市申请遭到FDA拒绝。2月3日，阿斯利康公告称，美国FDA就Saphnelo用于成人系统性红斑狼疮患者皮下给药的生物制品许可申请发出完整答复函，驳回了其狼疮治疗药物的自行注射剂型上市申请。总的来说，2026 年 开年以来，已有众多新药上市申请被拒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311144149a6b747a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311144149a6b747a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4530","LU1093756168.USD","IE00BFMHRM44.USD","BK4121","BK4532","LU1815336091.USD","LU0154236417.USD","NVOH","IE00BZ1G4Q59.USD","REGN","LU1093756325.SGD","LU0128526141.USD","BK4007","LU0390134368.USD","BK4585","LU0757428866.USD","INCY","IE00BKVL7J92.USD","NVOX","BK4599","BK4588","AZN","NVO","LU0029874061.USD"],"gpt_icon":0},{"id":"2614082376","title":"查爾斯河公司出售表現不佳資產，上調年度利潤預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082376","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082376?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 20:56","pubTimestamp":1772024211,"startTime":"0","endTime":"0","summary":"查尔斯河公司表示，这些举措旨在专注于与其核心产品组合具有更大协同效应的业务，将使 2026 年的报告收入减少 2 亿多美元，但调整后的营业利润率将提高至少 100 个基点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4T3ZL170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","IE00BFMHRM44.USD","BK4121","LU0882574055.USD","LU1989764748.USD","LU1989764664.SGD","LU1815336091.USD","LU1791710582.SGD","LU1261432733.SGD","LU0198837287.USD","LU0130102774.USD","LU0980610538.SGD","ADT","LU0128526141.USD","LU0648001328.SGD","LU0390134368.USD","BK4165","BK4585","LU0648000940.SGD","LU0477156797.USD","LU0130103400.USD","IQV","LU0757428866.USD","LU1201861249.SGD","CRL","BK4192","BK4588","LU0130518102.USD","LU0477156953.USD","LU1791710400.SGD","LU1201861165.SGD","LU0130517989.USD","LU0528227936.USD","LU0029874061.USD"],"gpt_icon":0},{"id":"1132999145","title":"查爾斯河國際實驗室：資產剝離預計將使2026年營收縮減逾2億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132999145","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132999145?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 20:06","pubTimestamp":1772021201,"startTime":"0","endTime":"0","summary":"查尔斯河实验室国际公司近日披露，公司实施的资产剥离计划预计将对2026财年的整体营收产生显著影响，缩减幅度预计超过2亿美元。这一战略调整反映了公司对业务组合的优化布局，旨在聚焦核心增长领域。尽管短期营收将面临压力，但该举措有望提升长期盈利能力与运营效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1815336091.USD","LU0390134368.USD","CRL","LU0128526141.USD","BK4121","LU0757428866.USD","BK4530","IE00BFMHRM44.USD","LU0029874061.USD","BK4588"],"gpt_icon":0},{"id":"1133242079","title":"艾昆緯簽署協議收購查爾斯河實驗室藥物發現資產，拓展端到端藥物研發能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1133242079","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133242079?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 20:06","pubTimestamp":1772021181,"startTime":"0","endTime":"0","summary":"艾昆纬已正式签署协议，将收购查尔斯河实验室旗下的药物发现相关资产。此次收购旨在进一步扩展艾昆纬在药物研发领域的端到端服务能力，强化其在全球生命科学行业的技术整合与服务覆盖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV","LU1989764664.SGD","LU0130518102.USD","LU0130517989.USD","LU1201861249.SGD","LU0477156797.USD","BK4121","LU0648001328.SGD","LU1261432733.SGD","LU0477156953.USD","LU0198837287.USD","LU0130102774.USD","BK4588","LU1201861165.SGD","LU0648000940.SGD","BK4585","LU0528227936.USD","BK4530","LU0130103400.USD","LU0980610538.SGD","LU0882574055.USD","LU1791710400.SGD","LU1791710582.SGD","LU1989764748.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}